Blue Crest Capital Management LTD Verastem, Inc. Transaction History

Blue Crest Capital Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $34,730 - $87,241	-27,784 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $77,517 - $113,636	27,784 New	27,784 $82,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $65,604 - $142,380	-20,311 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $59,277 - $86,150	8,641 Added 74.04%	20,311 $147,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $361,313 - $1.09 Million	-125,456 Reduced 91.49%	11,670 $80,000
Q1 2018 May 15, 2018	BUY	$2.92 - $3.81 $400,407 - $522,450	137,126 New	137,126 $409,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.